Ignite Creation Date:
2025-12-24 @ 12:19 PM
Ignite Modification Date:
2026-05-22 @ 8:16 AM
Study NCT ID:
NCT02688361
Status:
COMPLETED
Last Update Posted:
2019-01-24
First Post:
2016-02-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Bioequivalence Study of an Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil 2% Oral Solution
Sponsor:
GlaxoSmithKline
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Infections, Respiratory Tract | View |
Keywords: